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Abstract
Objective—To determine factors associated with low birth weight (LBW) in an urban Zambian 
cohort and investigate risk of adverse outcomes for LBW neonates.
Methods—The present retrospective cohort analysis used data recorded between February 2006 
and December 2012 for singletons and first-born twins delivered in the public health system of 
Lusaka, Zambia. Routine clinical data and generalized estimating equations were used to examine 
covariates associated with LBW (<2500 g) and describe outcomes of LBW.
Results—In total, 200 557 neonates were included, 21 125 (10.5%) of whom had LBW. 
Placental abruption, delivery before 37 weeks, and twin pregnancy were associated with LBW in 
multivariable analysis (P<0.01 for all). Compared with neonates weighing more than 2500 g, those 
with LBW were at higher risk of stillbirth (adjusted odds ratio [AOR] 8.6, 95% confidence interval 
[CI] 6.5–11.5), low Apgar score (AOR 5.7, 95% CI 4.6–7.2), admission to the neonatal intensive 
care unit (AOR 5.4, 95% CI 3.5–8.3), and very early neonatal death (AOR 6.2, 95% CI 3.7–10.3).
Conclusion—LBW neonates are at increased risk of adverse outcomes, including stillbirth and 
neonatal death, independent of pregnancy duration at delivery and multiple pregnancy. These 
findings underscore the need for early, comprehensive, and high-quality prenatal care.
Keywords
Low birth weight; Neonatal death; Obstetrics; Perinatal outcomes; Stillbirth; Sub-Saharan Africa
✰Presented at the 2015 FIGO World Congress; October 4–9, 2015; Vancouver, BC, Canada: P0135
*Corresponding author: Carla J. Chibwesha, University of North Carolina at Chapel Hill, 3009 Old Clinic Building, Campus Box 
7577, Chapel Hill, NC 277599-7577, USA. Tel.: +1 919 966 8935; fax: +1 919 966 6049. carla_chibwesha@med.unc.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of interest
The authors have no conflicts of interest.
HHS Public Access
Author manuscript
Int J Gynaecol Obstet. Author manuscript; available in PMC 2017 September 01.
Published in final edited form as:
Int J Gynaecol Obstet. 2016 September ; 134(3): 309–314. doi:10.1016/j.ijgo.2016.03.021.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
1. Introduction
Most cases of low birth weight (LBW; <2500 g) result from preterm birth (either 
spontaneous or indicated), intrauterine growth restriction, or, less commonly, congenital 
anomalies. LBW neonates—particularly those born prematurely—are at risk of mortality, 
severe morbidity, and developmental problems [1], which could in turn have long-term 
effects on health during adulthood and on socioeconomic outcomes, including education and 
income [2]. Despite improvements in newborn and child health indicators over the past two 
decades [3], LBW births remain common, particularly in low- and middle-income countries 
(LMICs) [4], where approximately 10%–20% of neonates meet the criteria for LBW [1].
Globally, LBW is associated with various maternal and obstetric factors, such as 
malnutrition and poor weight gain, infection (including malaria and HIV), prepartum 
hemorrhage, chronic hypertension and hypertensive disorders of pregnancy, diabetes, 
abnormal placentation, multiple pregnancy, and preterm birth [5]. Some of these factors are 
modifiable through early and comprehensive prenatal care. Examples include nutritional 
supplementation, screening and treatment for infectious diseases, progesterone for the 
prevention of recurrent preterm birth, and smoking cessation. Socioeconomic factors—
including education, income, and inequality—and access to prenatal care are also important 
determinants of pregnancy outcomes and birth weight [6,7]. Because of its association with 
multiple markers of poor health and limited access to care, LBW has long been considered 
an important public health indicator [1]. However, published data from Sub-Saharan African 
cohorts remain scarce. The use of birth weight rather than pregnancy duration as an outcome 
measure is particularly relevant in LMIC settings, where it is difficult to accurately 
determine the length of pregnancy because women often present for care late in pregnancy 
[8], and obstetric ultrasonography is not commonly available or is not used to establish the 
estimated delivery date [9]. As a result, distinguishing between intrauterine growth 
restriction and preterm birth is often challenging.
The aims of the present study were to determine factors associated with LBW among 
Zambian women receiving care in an urban public health system and to investigate whether 
LBW neonates were at higher risk of adverse perinatal outcomes compared with neonates 
weighing 2500 g or more at birth.
2. Materials and methods
The present retrospective cohort analysis used prenatal, delivery, and postnatal data from the 
public Maternal, Newborn, and Child Health (MNCH) system in Lusaka, Zambia, recorded 
between February 1, 2006, and December 31, 2012. Ethics approval for the present analysis 
was obtained from the University of Zambia Biomedical Research Ethics Committee 
(Lusaka, Zambia) and the institutional review board of the University of North Carolina at 
Chapel Hill (Chapel Hill, NC, USA). Because this was a secondary analysis of routinely 
collected clinical data, a waiver of consent was granted by the ethics committees.
Lusaka—Zambia’s capital and largest city—has an extensive network of primary health 
clinics where MNCH services are mostly provided free from user fees. Primary health 
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clinics are staffed by midwives and nurses, who provide prenatal, delivery, and postnatal 
services to low-risk women and neonates. High-risk pregnancies are referred to the 
University Teaching Hospital in Lusaka and attended by general medical officers, 
obstetrician–gynecologists, pediatricians, and other specialists. Clinical MNCH data are 
captured in an electronic medical record known as the Zambia Perinatal Records System 
(ZEPRS) [8], which was introduced in 2006.
The analysis included singletons and first-born twins delivered in a primary health clinic or 
at the University Teaching Hospital for whom the pregnancy duration estimate was deemed 
“reliable” and for whom a minimum complement of delivery information (date of birth, birth 
weight, and birth outcome) was recorded in ZEPRS. Because ultrasonography is not 
commonly used to determine a woman’s estimated delivery date in Zambia, clinical dating 
criteria—last menstrual period (LMP) and symphysis–fundal height—were applied to 
estimate the pregnancy duration. Women were included only if their LMP had been recorded 
and if, when appropriate, the estimated pregnancy duration based on the symphysis–fundal 
height did not differ by more than 3 weeks from that estimated by the LMP method. Mothers 
with twins were counted once and only the birth weight of the first twin was considered. The 
analysis was limited to viable deliveries, defined as a pregnancy duration of 28 weeks or 
more and a birth weight of 1000 g or more, as is customary in the Zambian setting.
The present study had two objectives. The first was to determine demographic, 
socioeconomic, and/or obstetric factors associated with LBW in singleton and twin 
pregnancies. The second was to quantify the relative risk of adverse perinatal outcomes in 
LBW neonates compared with neonates weighing more than 2500 g.
For the first objective, the primary outcome measure was LBW. The following information 
was obtained from ZEPRS: maternal age, parity, obstetric history (prior stillbirth and prior 
preterm birth), medical history (pregestational hypertension [systolic blood pressure ≥140 
mm Hg or diastolic blood pressure ≥90 mm Hg] and pregestational diabetes), and prenatal 
care (pregnancy duration at first visit, singleton or twin pregnancy, body mass index, 
hemoglobin concentration, syphilis serostatus, HIV serostatus, hypertension, and placental 
abruption). Perinatal HIV infection was confirmed by cross-referencing ZEPRS data with 
the electronic database at the laboratory that had performed the neonatal HIV test. 
Pregnancy duration was calculated by combining information on LMP and symphysis–
fundal height, if appropriate. Predictors of LBW were investigated in both univariable and 
multivariable analyses using generalized estimating equations to account for clustering. 
Variables for inclusion in the multivariable model were selected a priori. Crude and adjusted 
odds ratios were calculated with accompanying 95% confidence intervals.
For the second objective, LBW neonates and those weighing more than 2500 g were 
compared, and crude and adjusted odds were estimated for five adverse outcomes: stillbirth, 
Apgar score less than 7 at 1 minute of life, admission to the neonatal intensive care unit 
(NICU), very early neonatal death (death within 24 hours), and perinatal HIV transmission 
within the first 6 weeks of life. In a multivariable analysis, each outcome model was 
adjusted for the variables included in the multivariable predictors model (maternal age, 
parity, prior stillbirth, prior preterm birth, pregestational diabetes, pregnancy duration at first 
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prenatal care visit, multiple pregnancy, body mass index, hemoglobin concentration, syphilis 
serostatus, HIV serostatus, hypertension during the current pregnancy, placental abruption, 
and pregnancy duration at delivery). The HIV transmission model was also adjusted for the 
maternal antiretroviral regimen. Once again, a generalized estimating equation modeling 
approach was adopted and odds ratios were calculated with accompanying 95% confidence 
intervals.
Statistical analyses were performed using Stata version 12 (Statacorp, College Station, TX, 
USA). P<0.05 was considered statistically significant.
3. Results
During the study period, 244 986 pregnancies were registered in Lusaka’s public MNCH 
system and recorded in ZEPRS. A total of 44 429 (18.1%) pregnancies were excluded from 
the analysis; therefore, 200 557 singleton or first-born twin deliveries were eligible for 
inclusion in the analysis cohort (Figure 1).
The median maternal age was 25 years and most women were multiparous (Table 1). 
Consistent with results previously reported by our group [8], most women presented for their 
first prenatal care visit in the second trimester. The median body mass index at the first 
prenatal care visit was in the healthy range. Baseline prenatal care laboratory tests included 
hemoglobin, syphilis, and HIV testing. Overall, 9616 (10.0%) women were anemic with a 
hemoglobin concentration of less than 100 g/L, 4761 (2.4%) had a positive rapid plasma 
reagin test for syphilis, and 42 995 (21.4%) were HIV seropositive.
With respect to the obstetric history, 3221 (2.3%) women reported a stillbirth in a prior 
pregnancy and 5564 (4.0%) had a history of preterm birth (Table 1). A history of 
hypertension before pregnancy was reported by 2250 (1.1%) women, and 215 (0.1%) 
reported a diagnosis of pregestational diabetes. Hypertension during prenatal care or 
delivery was diagnosed in 13 473 (6.7%) women and placental abruption in 122 (0.1%).
A total of 21 125 (10.5%) neonates in the present cohort met the criteria for LBW. There 
were 3626 stillbirths and 590 very early neonatal deaths, corresponding to a crude stillbirth 
rate of 18 per 1000 deliveries and a crude rate of very early neonatal death of 3 per 1000 live 
births.
The results of the univariable and multivariable analyses of factors associated with LBW are 
presented in Table 2. In multivariable analysis, extremes of maternal age (<20 years, ≥30 
years), primiparity, prior stillbirth, prior preterm birth, pregestational diabetes, initial 
prenatal care visit during the second or third trimester, low body mass index, anemia, 
syphilis, HIV infection, and hypertension during the current pregnancy were all associated 
with increased odds of delivering an LBW neonate.
Additionally, the odds of LBW were five times higher among pregnancies complicated by 
placental abruption than among pregnancies in which placental abruption was not diagnosed 
(Table 2). Compared with neonates born between 37 and 42 weeks of pregnancy, those born 
between 28 and 34 weeks of pregnancy had six-fold higher odds of LBW, whereas those 
Chibwesha et al. Page 4
Int J Gynaecol Obstet. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
born at 35 or 36 weeks had two-fold higher odds (Table 2). Most importantly, the odds of 
LBW were more than 34 times higher in twins than in singletons (Table 2), with twins 
comprising 1.4% of all neonates in the analysis and 9.6% of LBW neonates.
In the multivariable analysis of perinatal outcomes associated with LBW, the adjusted odds 
of stillbirth were 8.6 times higher among LBW neonates than among neonates weighing 
more than 2500 g (Table 3). Moreover, LBW neonates were substantially more likely than 
neonates weighing more than 2500 g to have a low Apgar score and to be admitted to the 
NICU (Table 3). They also had six-fold increased odds of very early neonatal death (Table 
3). However, LBW did not seem to increase the risk of mother-to-child HIV transmission at 
approximately 6 weeks of life (Table 3).
4. Discussion
The present cohort study provides important perinatal findings from the largest district 
health system in Zambia. Nearly 11% of neonates in the present cohort met the criteria for 
LBW. Notably, on the basis of a multivariable analysis, pregnancies complicated by 
placental abruption were five times more likely to result in LBW than were uncomplicated 
pregnancies. Delivery before 37 weeks of pregnancy increased the risk of LBW by a factor 
of two (delivery at 35–36 weeks) to six (delivery at 28–34 weeks). Most worrisome was the 
finding that the odds of LBW were more than 34 times higher in twins than in singletons, 
independent of the pregnancy duration at delivery. This is particularly concerning in a setting 
where twins are also at high risk for stillbirth, neonatal death, and other adverse outcomes 
[10,11], and in view of the increasing rate of twin pregnancies globally [12].
The prevalence of LBW observed in the present cohort is consistent with Demographic and 
Health Survey data from 2013–2014 [13], which estimate that 9% of neonates in Zambia are 
born weighing less than 2500 g. Several of the maternal and obstetric risk factors associated 
with LBW in the present analysis, including prior stillbirth and preterm birth, hypertension, 
placental abruption, and anemia, are also consistent with the published literature [14–16].
The present study sought to quantify the extent to which neonates with LBW experienced 
adverse outcomes. These neonates were at markedly higher risk for stillbirth, a low Apgar 
score, NICU admission, and very early neonatal death when compared with neonates with a 
birth weight of 2500 g or more. These findings provide further evidence that although 
prenatal care attendance in Zambia is high (>95%) [13], a redoubling of effort is required to 
ensure complete coverage of prenatal and obstetric services as well as initiation of prenatal 
care early in pregnancy [17]. Increased clinical suspicion and the introduction of routine 
ultrasonography are also needed for pregnancy dating, early identification of twin 
pregnancies, and the monitoring of growth-restricted fetuses and other high-risk pregnancies 
[18,19] in LMIC settings. Furthermore, routine neonatal resuscitation has been demonstrated 
to improve outcomes for both term and preterm neonates in low-resource settings [20], 
including in Zambia [21]. If implemented fully and correctly, simple resuscitation 
algorithms, such as the Helping Babies Breathe protocol [22], are powerful tools to reduce 
neonatal morbidity and mortality—as are interventions such as kangaroo care (comprising 
skin-to-skin warming, breastfeeding, and bonding) [23] and cord care [24].
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The strengths of the present analysis include the large size of the cohort and the use of “real-
world” clinical data from a large public sector health system. The outcome variable of LBW 
is also highly relevant for a low-resource setting such as Zambia, because ultrasonography is 
not commonly used either to confirm pregnancy dating or to monitor fetal growth. The 
finding that some 39% of deliveries were categorized as occurring before 37 weeks seems 
implausible, and reconfirms the decision to use LBW—rather than preterm birth—as the 
primary outcome measure.
The study also has several limitations. First, because routine clinical records were used, it 
was not possible to explore additional risk factors and to control for potential confounders 
such as tobacco, alcohol, and illicit drug use, violence and injury, income, healthcare 
decision making, food security, middle-upper-arm circumference, malaria, helminth 
infections, tuberculosis, sexually transmitted infections, and other medical comorbidities. 
Second, and again because routine clinical records were used, the adverse perinatal 
outcomes that could be examined only represent a subset of those that may be of interest. 
Notably, it was not possible to investigate neonatal morbidity, 7- and 28-day mortality, or 
neurodevelopmental outcomes in the present cohort. Third, because deliveries in Zambia 
occurring at less than 28 weeks and/or with a birth weight of less than 1000 g are routinely 
considered spontaneous abortions and these fetuses are not routinely resuscitated, the 
present analysis could underestimate adverse outcomes in extremely premature neonates and 
those with a very low birth weight. Fourth, some very early neonatal deaths may have been 
misclassified as stillbirths, a practice we have observed in Zambia. Such misclassification 
would result in an overestimation of stillbirths and an underestimation of neonatal deaths.
In conclusion, 11% of the neonates born in Lusaka’s public health system met the criteria 
for LBW and these newborns were at markedly increased risk for adverse outcomes, 
including stillbirth, a low Apgar score, NICU admission, and very early neonatal death. 
Placental abruption, delivery before 37 weeks, and twin pregnancy increased the risk of 
LBW substantially. Taken together, these results underscore a need for early, comprehensive, 
and high-quality prenatal care. They also indicate a role for accurate pregnancy dating and 
growth monitoring with ultrasonography, particularly for high-risk pregnancies. Finally, the 
expansion of coverage of simple and effective neonatal interventions, such as routine 
resuscitation, kangaroo care, and cord care, is critical to reducing the risk of morbidity and 
mortality for neonates with LBW in Zambia and other low-resource settings.
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Synopsis
Low birth weight affects 11% of deliveries in urban Zambia and is associated with 
adverse perinatal outcomes, including stillbirth and neonatal death.
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Figure 1. 
Flow of patients through the study. Abbreviations: ZEPRS, Zambia Perinatal Records 
System; EGA, estimated gestational age. a For twin deliveries, information for first-born 
twin included. b Pregnancy duration ≥28 weeks and birth weight ≥1000 g.
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Table 1
Maternal and newborn characteristicsa,b
Variable Total cohort
(n=200 557)
Birth weight
≥2500 g
(n=179 432)
Birth weight
<2500 g
(n=21 125)
P value
Maternal age, y 25 (20–29) 25 (21–29) 24 (20–29) <0.001c
  <20 38 062 (19.0) 32 786 (18.3) 5276 (25.0) <0.001d
  20–24 61 673 (30.8) 55 402 (30.9) 6271 (29.7)
  25–30 52 288 (26.1) 47 492 (26.5) 4796 (22.7)
  ≥30 48 534 (24.2) 43 752 (24.4) 4782 (22.6)
Parity 1 (0–3) 1 (0–3) 1 (0–2) <0.001c
  Primiparous 62 205 (31.0) 53 513 (29.8) 8692 (41.1) <0.001d
Pregnancy duration at 1st prenatal care visit, wk 22 (18–26) 22 (18–26) 22 (18–26) <0.001c
  <14 11 565 (5.8) 10 235 (5.7) 1330 (6.3) <0.001d
  14–23 106 603
(53.2)
94 896 (52.9) 11 707 (55.4)
  ≥24 82 389 (41.1) 74 301 (41.4) 8088 (38.3)
Baseline body mass indexe 24 (21–26) 24 (22–26) 23 (21–25) <0.001c
  <20 13 588 (6.8) 11 454 (6.4) 2134 (10.1) <0.001d
  20–24 60 776 (30.3) 53 583 (29.9) 7193 (34.0)
  ≥25 57 438 (28.6) 52 752 (29.4) 4686 (22.2)
  Missing 68 755 (34.3) 61 643 (34.4) 7112 (33.7)
Prior stillbirthf 3221/138 352(2.3)
2798/125 919 (2.2) 423/12 433
(3.4) <0.001
d
Prior preterm birthf 5564/138 352(4.0)
4702/125 919 (3.7) 862/12 433
(6.9) <0.001
d
Twin pregnancy 2860 (1.4) 824 (0.5) 2036 (9.6) <0.001d
Hypertension during prenatal care or delivery 13 473 (6.7) 11 509 (6.4) 1964 (9.3) <0.001d
Pregestational hypertension
  Yes 2250 (1.1) 1991 (1.1) 259 (1.2) <0.001d
  No 156 985
(78.3)
140 689 (78.4) 16 296 (77.1)
  Unknown 41 322 (20.6) 36 752 (20.5) 4570 (21.6)
Pregestational diabetes
  Yes 215 (0.1) 188 (0.1) 27 (0.1) <0.001d
  No 163 879
(81.7)
146 820 (81.8) 17 059 (80.8)
  Unknown 36 463 (18.2) 32 424 (18.1) 4039 (19.1)
Placental abruption 122 (0.1) 72 (<0.1) 50 (0.2) <0.001d
Baseline hemoglobin, g/L 116 (107–
125)
116 (107–125) 116 (105–
124) <0.001
c
  <80 1124 (0.6) 904 (0.5) 220 (1.0) <0.001d
  80–90 8492 (4.2) 7247 (4.0) 1245 (5.9)
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Variable Total cohort
(n=200 557)
Birth weight
≥2500 g
(n=179 432)
Birth weight
<2500 g
(n=21 125)
P value
  ≥100 86 359 (43.1) 77 394 (43.1) 8965 (42.4)
  Unknown 104 582
(52.1)
93 887 (52.3) 10 695 (50.6)
Baseline syphilis by rapid plasma reagin
  Reactive, not treated 1489 (0.7) 1304 (0.7) 185 (0.9) <0.001d
  Reactive, treated 3272 (1.6) 2844 (1.6) 428 (2.0)
  Nonreactive 138 025
(68.8)
123 940 (69.1) 14 085 (66.7)
  Not done/documented 57 771 (28.8) 51 344 (28.6) 6427 (30.4)
Baseline HIV serostatus
  Infected 42 995 (21.4) 37 046 (20.6) 5949 (28.2) <0.001d
  Uninfected 151 553
(75.6)
136 991 (76.3) 14 562 (68.9)
  Unknown 6009 (3.0) 5395 (3.0) 614 (2.9)
Antiretrovirals given during prenatal care/delivery g
  None 1011/42 995
(2.4)
814/37 046 (2.2) 197/5949
(3.3) <0.001
d
  Nevirapine 6059/42 995
(14.1)
5069/37 046 (13.7) 990/5949
(16.6)
  Zidovudine 23 941/42 995
(55.7)
21 060/37 046
(56.8)
2881/5949
(48.4)
  Highly active antiretroviral therapy 11 984/42 995
(27.9)
10 103/37 046
(27.3)
1881/5949
(31.6)
Pregnancy duration at delivery, wk 37 (35–39) 38 (35–39) 35 (32–37) <0.001c
  28–34 28 407 (14.2) 20 634 (11.5) 7773 (36.8) <0.001d
  35–36 49 751 (24.8) 43 655 (24.3) 6096 (28.9)
  37–42 108 613
(54.2)
102 041 (56.9) 6572 (31.1)
  43–44 13 786 (6.9) 13 102 (7.3) 684 (3.2)
aValues are given as median (range), number (percentage), or number/total number, unless indicated otherwise.
b
Mothers with twins are accounted for only once and only the birth weight of the first twin is considered. Prior stillbirth, prior preterm birth, 
hypertension during prenatal care or delivery, and placental abruption are coded as yes/not yes variables and therefore do not have any missing 
values.
cWilcoxon rank-sum test.
d
Pearson χ2 test.
eCalculated as weight in kilograms divided by the square of height in meters.
f
Denominators exclude primiparas.
g
Includes women with HIV infection only.
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Table 2
Risk factors for low birth weighta
Variable Univariable analysis Multivariable analysis
Crude odds ratio
(95% confidence
interval)b
P value Adjusted odds ratio
(95% confidence
interval)c
P value
Maternal age, y
  <20 1.6 (1.3–1.9) <0. 001 1.3 (1.1–1.5) 0.01
  20–24 1.1 (1.0–1.3) 0.041 1.1 (0.9–1.2) 0.397
  25–30 1.0 1.0
  ≥30 1.1 (1.1–1.1) <0.001 1.3 (1.1–1.4) <0.001
Primiparous 1.7 (1.4–2.0) <0.001 1.8 (1.6–2.0) <0.001
Pregnancy duration at 1st prenatal care visit, wk
  <14 1.0 1.0
  14–24 1.0 (0.9–1.0) 0.126 1.3 (1.1–1.4) 0.004
  >24 0.8 (0.8–0.9) 0.003 1.5 (1.2–1.8) <0.001
Baseline BMId
  <20 1.4 (1.3–1.5) <0.001 1.5 (1.3–1.7) <0.001
  20–24 1.0 1.0
  ≥25 0.7 (0.6–0.7) <0.001 0.7 (0.6–0.7) <0.001
Prior stillbirth 1.3 (1.2–1.4) <0.001 1.5 (1.3–1.7) <0.001
Prior preterm birth 1.6 (1.4–1.8) <0.001 1.6 (1.4–1.9) <0.001
Twin pregnancy 23.1 (19.1–27.9) <0.001 34.4 (28.9–41.0) <0.001
Hypertension during PNC or delivery 1.5 (1.2–1.8) <0.01 1.6 (1.4–2.0) <0.001
Pregestational hypertension 1.1 (0.9–1.4) 0.333 1.2 (1.0–1.5)
Pregestational diabetes 1.2 (1.0–1.6) 0.112 1.9 (1.1–3.1) 0.013
Placental abruption 5.9 (4.6–7.6) <0.001 5.2 (2.8–9.4) <0.001
Baseline hemoglobin, g/L
  <80 2.1 (1.7–2.6) <0.001 1.6 (1.3–1.9) <0.001
  80–90 1.5 (1.4–1.6) <0.001 1.2 (1.1–1.4) 0.008
  ≥100 1.0 1.0
Baseline syphilis by rapid plasma reagin
  Reactive, not treated 1.3 (1.1–1.4) 0.003 0.9 (0.7–1.2) 0.409
  Reactive, treated 1.3 (1.2–1.5) <0.001 1.0 (0.8–1.3) 0.893
  Nonreactive 1.0 1.0
Positive HIV serostatus at baseline 1.5 (1.5–1.6) <0.001 1.5 (1.4–1.7) <0.001
Antiretrovirals given during prenatal care/delivery
  None 1.8 (1.5–2.1) <0.001 –
  Nevirapine 1.4 (1.2–1.7) <0.001 –
  Zidovudine 1.0 –
Highly active antiretroviral therapy 1.4 (1.3–1.4) <0.001 –
Pregnancy duration at delivery, wk
Int J Gynaecol Obstet. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Chibwesha et al. Page 14
Variable Univariable analysis Multivariable analysis
Crude odds ratio
(95% confidence
interval)b
P value Adjusted odds ratio
(95% confidence
interval)c
P value
  28–34 5.9 (4.0–8.6) <0.001 6.3 (4.3–9.4) <0.001
  35–36 2.2 (1.9–2.5) <0.001 2.2 (1.8–2.7) <0.001
  37–42 1.0 1.0
  43–44 0.8 (0.7–0.9) <0.001 0.7 (0.6–0.7) <0.001
Abbreviations: BMI, body mass index; CI, confidence interval; HAART, highly active antiretroviral therapy; NS, not significant; NVP, nevirapine; 
OR, odds ratio; PNC, prenatal care; RPR, rapid plasma reagin; ZDV, zidovudine.
a
Missing and unknown values are excluded from the analysis.
bCalculated from univariable logistic regression of the effect of each factor on odds of low birth weight.
cCalculated from multivariable logistic regression of the effect of low birth weight on each of the outcomes, adjusting for all risk factors shown 
except antiretroviral regimen. The sample size for the complete-case analysis adjusted regression 41 595.
dCalculated as weight in kilograms divided by the square of height in meters.
Int J Gynaecol Obstet. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Chibwesha et al. Page 15
Ta
bl
e 
3
Pr
eg
na
nc
y 
ou
tc
om
es
a,
b
O
ut
co
m
e
Bi
rt
h 
w
ei
gh
t
≥2
50
0 
g
(n
=1
79
 43
2)
Bi
rt
h 
w
ei
gh
t
<
25
00
 g
(n
=2
1 1
25
)
U
ni
v
a
ri
ab
le
 a
na
ly
sis
M
ul
tiv
a
ri
ab
le
 a
na
ly
sis
C
ru
de
 o
dd
s
ra
tio
 (9
5%
co
n
fid
en
ce
in
te
rv
a
l)c
P 
v
a
lu
e
A
dju
ste
d o
dd
s
ra
tio
 (9
5%
co
n
fid
en
ce
in
te
rv
a
l)d
P 
v
a
lu
e
St
ill
bi
rth
 
 
N
o
17
7 
62
9/
17
9 
43
2
(99
.0)
19
 3
02
/2
1 
12
5
(91
.4)
1.
0
1.
0
 
 
Ye
s
18
03
/1
79
 4
32
(1.
0)
18
23
/2
1 
12
5
(8.
6)
9.
3 
(7.
0–
12
.4)
<
0.
00
1
8.
6 
(6.
5–
11
.5)
<
0.
00
1
A
pg
ar
 s
co
re
 <
7 
at
 1
 m
in
ut
e
N
o
16
0 
62
7/
16
4 
63
8
(97
.6)
16
 5
50
/1
8 
99
5
(87
.1)
1.
0
1.
0
Ye
s
40
11
/1
64
 6
38
(2.
4)
24
45
/1
8 
99
5
(12
.9)
5.
9 
(4.
5–
7.7
)
<
0.
00
1
5.
7 
(4.
6–
7.2
)
<
0.
00
1
A
dm
iss
io
n 
to
 th
e 
ne
on
at
al
 in
te
ns
iv
e
ca
re
 u
n
it
 
 
N
o
17
8 
41
1/
17
9 
43
2
(99
.4)
20
 2
90
/2
1 
12
5
(96
.0)
1.
0
1.
0
 
 
Ye
s
10
21
/1
79
 4
32
(0.
6)
83
5/
21
 1
25
(4.
0)
7.
2 
(4.
8–
10
.8)
<
0.
00
1
5.
4 
(3.
5–
8.3
)
<
0.
00
1
Ve
ry
 e
ar
ly
 n
eo
na
ta
l d
ea
th
 (<
24
 h)
 
 
N
o
17
7 
33
5/
17
7 
62
9
(99
.8)
19
 0
09
/1
9 
30
5
(98
.5)
1.
0
1.
0
 
 
Ye
s
29
4/
17
7 
62
9
(0.
2)
29
6/
19
 3
05
(1.
5)
9.
4 
(6.
1–
14
.6)
<
0.
00
1
6.
2 
(3.
7–
10
.3)
<
0.
00
1
H
IV
 tr
an
sm
iss
io
n 
by
 6
 w
ee
ks
 o
f l
ife
 e
 
 
N
o
95
35
/1
0 
11
1
(94
.3)
11
19
/1
21
2
(92
.3)
1.
0
1.
0
 
 
Ye
s
57
6/
10
 1
11
 (5
.7)
93
/1
21
2 
(7.
7)
1.
4 
(1.
0–
1.7
)
0.
00
5
1.
1 
(0.
7–
1.7
)
0.
64
a V
al
ue
s g
iv
en
 a
s 
n
u
m
be
r/t
ot
al
 n
um
be
r (
pe
rce
nta
ge
) u
nle
ss 
ind
ica
ted
 ot
he
rw
ise
.
b M
iss
in
g 
va
lu
es
 ex
cl
ud
ed
 fr
om
 th
e 
an
al
ys
is.
 S
til
lb
irt
h:
 c
ru
de
 O
R 
n=
20
0 
55
7,
 ad
jus
ted
 O
R 
n=
76
 29
2; 
Ap
ga
r 
sc
o
re
 <
7:
 c
ru
de
 O
R 
n=
18
3 
63
3,
 ad
jus
ted
 O
R 
n=
69
 73
3; 
ad
mi
ssi
on
 to
 th
e n
eo
na
tal
 in
ten
siv
e 
ca
re
 
u
n
it:
 c
ru
de
 O
R 
n=
20
0 
55
7,
 ad
jus
ted
 O
R 
n=
76
 29
2; 
ve
ry
 e
ar
ly
 n
eo
na
ta
l d
ea
th
: c
ru
de
 O
R 
n=
19
6 
93
4,
 ad
jus
ted
 O
R 
n=
74
 87
6; 
HI
V 
tra
nsm
iss
ion
 by
 6 
we
ek
s o
f li
fe:
 cr
ud
e O
R 
n=
11
 32
3, 
ad
jus
ted
 O
R 
n=
44
99
.
Int J Gynaecol Obstet. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Chibwesha et al. Page 16
c C
al
cu
la
te
d 
fro
m
 u
ni
v
ar
ia
bl
e 
lo
gi
sti
c 
re
gr
es
sio
n 
of
 th
e 
ef
fe
ct
 o
f l
ow
 b
irt
h 
w
ei
gh
t o
n 
ea
ch
 o
f t
he
 o
ut
co
m
es
.
d C
al
cu
la
te
d 
fro
m
 m
ul
tiv
ar
ia
bl
e 
lo
gi
sti
c 
re
gr
es
sio
n 
of
 th
e 
ef
fe
ct
 o
f l
ow
 b
irt
h 
w
ei
gh
t o
n 
ea
ch
 o
f t
he
 o
ut
co
m
es
, a
dju
sti
ng
 fo
r a
ll r
isk
 fa
ct
or
s 
sh
ow
n
 in
 T
ab
le
 2
 ex
ce
pt
 a
nt
ire
tro
v
ira
l r
eg
im
en
. O
dd
s r
at
io
s f
or
 
co
v
ar
ia
te
s h
av
e 
be
en
 o
m
itt
ed
 fo
r p
re
se
nt
at
io
n 
pu
rp
os
es
.
e L
im
ite
d 
to
 m
ot
he
rs
 k
no
w
n
 to
 h
av
e 
H
IV
 in
fe
ct
io
n.
Int J Gynaecol Obstet. Author manuscript; available in PMC 2017 September 01.
